Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Analysis of Factors Influencing Discontinuation of Treatment and Development of Adverse Events with Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)(2011)10.5649/jjphcs.37.631Source: DataRank Database

Analysis of Factors Influencing Discontinuation of Treatment and Development of Adverse Events with Sorafenib in Patients with Advanced Hepatocellular Carcinoma is a research paper published in Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) (2011). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 0.00)OA: bronzeTopics (12)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Masahide Fukudo,Sachio Fukatsu,Ikuko Yano,Toshiya Katsura,Aya Shimogai

Live enrichment

PubMed:23304386 OpenAlex:https://openalex.org/W2318402467

FWCI

0.00

Citation Percentile

0.2%

bronze

journalhttps://www.jstage.jst.go.jp/article/jjphcs/37/11/37_631/_pdf

publisherhttps://www.jstage.jst.go.jp/article/jjphcs/37/11/37_631/_pdf

journalhttps://doi.org/10.5649/jjphcs.37.631

Fields of Study

Colorectal Cancer Treatments and StudiesHepatocellular Carcinoma Treatment and PrognosisMultiple Myeloma Research and Treatments

Keywords

DiscontinuationSorafenibMedicineAdverse effectHepatocellular carcinomaInternal medicineDiarrheaSurgeryGastroenterology

Sustainable Development Goals

SDG 0: Good health and well-being

Analysis of Factors Influencing Discontinuation of Treatment and Development of Adverse Events with Sorafenib in Patients with Advanced Hepatocellular Carcinoma

FAIR Checklist

Authors (5)

Impact

Open Access

Topics